Hearing: Reforming the Drug Compounding Regulatory Framework
Subcommittee on Health (Committee on Energy and Commerce)
Subcommittee on Health (Committee on Energy and Commerce)
Tuesday, July 16, 2013 (3:00 PM)
2123 RHOB
Washington, D.C. 20515-20515
Witnesses
Dr. Carmen A. Catizone
Executive Director, National Association of Boards of Pharmacy, Mount Prospect, IL
Added 07/12/2013 at 02:22 PM
Executive Director, National Association of Boards of Pharmacy, Mount Prospect, IL
Mr. Allan Coukell
Deputy Director, Medical Programs, The Pew Charitable Trusts, Washington, D.C.
Added 07/12/2013 at 02:22 PM
Deputy Director, Medical Programs, The Pew Charitable Trusts, Washington, D.C.
Mr. Jeffrey K. Francer
Assistant General Counsel, Pharmaceutical Research and Manufacturers of America, Washington, D.C.
Added 07/12/2013 at 02:22 PM
Assistant General Counsel, Pharmaceutical Research and Manufacturers of America, Washington, D.C.
Dr. David Gaugh
Vice President, Regulatory Sciences, Generic Pharmaceutical Association, Washington, D.C.
Added 07/12/2013 at 02:22 PM
Vice President, Regulatory Sciences, Generic Pharmaceutical Association, Washington, D.C.
Dr. B. Douglas Hoey
Chief Executive Officer, National Community Pharmacists Association, Alexandria, VA
Added 07/12/2013 at 02:22 PM
Chief Executive Officer, National Community Pharmacists Association, Alexandria, VA
Dr. David G. Miller
Executive Vice President and CEO, International Academy of Compounding Pharmacists, Alexandria, VA
Added 07/12/2013 at 02:22 PM
Executive Vice President and CEO, International Academy of Compounding Pharmacists, Alexandria, VA
Dr. Kasey K. Thompson
Vice President, Planning and Communication, American Society of Health-System Pharmacists, Bethesda, MD
Added 07/12/2013 at 02:22 PM
Vice President, Planning and Communication, American Society of Health-System Pharmacists, Bethesda, MD
Dr. Janet Woodcock
Director, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD
Added 07/12/2013 at 02:22 PM
Director, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD
Text of Legislation
- H.R. 2186--To amend the Federal Food, Drug, and Cosmetic Act to provide for the compounding of drug products [PDF]Added 07/12/2013 at 02:15 PM
- S. 959--To amend the Federal Food, Drug, and Cosmetic Act with respect to compounding drugs [PDF]Added 07/12/2013 at 02:15 PM
- Discussion Draft--To amend section 503A of the Federal Food, Drug, and Cosmetic Act with respect to pharmacy compounding [PDF]Added 07/12/2013 at 02:15 PM
No comments:
Post a Comment